
Moderna Inc MRNA.O:
MODERNA FILES FDA APPLICATION FOR THE LP.8.1 TARGETING COVID-19 VACCINE
MODERNA: SUBMISSION BASED ON GUIDANCE FROM U.S. FDA, WHICH ADVISED THAT COVID-19 VACCINES SHOULD BE UPDATED TO A MONOVALENT JN.1 LINEAGE - WEBSITE
Source text: [ID:]